NASDAQ:IBBiShares Nasdaq Biotechnology ETF Stock Price, Forecast & News

iShares Nasdaq Biotechnology ETF's stock was trading at $106.97 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, IBB shares have increased by 25.1% and is now trading at $133.81.
View which stocks have been most impacted by COVID-19.

iShares Nasdaq Biotechnology ETF declared a quarterly dividend on Wednesday, March 25th. Stockholders of record on Thursday, March 26th will be given a dividend of $0.0554 per share on Tuesday, March 31st. This represents a $0.22 dividend on an annualized basis and a yield of 0.17%. The ex-dividend date is Wednesday, March 25th.
View iShares Nasdaq Biotechnology ETF's dividend history.

iShares Nasdaq Biotechnology ETF shares split on the morning of Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly issued shares were distributed to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of iShares Nasdaq Biotechnology ETF stock prior to the split would have 300 shares after the split.

Press coverage about IBB stock has trended very negative recently, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. iShares Nasdaq Biotechnology ETF earned a daily sentiment score of -3.2 on InfoTrie's scale. They also gave headlines about the financial services provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future.
View the latest news about iShares Nasdaq Biotechnology ETF.

iShares Nasdaq Biotechnology ETF saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 21,710,000 shares, an increase of 28.5% from the May 31st total of 16,900,000 shares. Based on an average daily volume of 3,567,900 shares, the days-to-cover ratio is currently 6.1 days.
View iShares Nasdaq Biotechnology ETF's Short Interest.

Some companies that are related to iShares Nasdaq Biotechnology ETF include DNP Select Income Fund (DNP), Nuveen Municipal Value Fund (NUV), Adams Diversified Equity Fund (ADX), PIMCO Corporate&Income Opportunity Fund (PTY), Tri-Continental (TY), Gabelli Equity Trust (GAB), Royce Value Trust (RVT), Hercules Capital (HTGC), Liberty All-Star Equity Fund (USA), Boulder Growth & Income Fund (BIF), Tortoise Energy Infrastructure (TYG), Blackrock Muniyield Insured Fund (MYI), AllianceBernstein Global Hgh Incm Fd (AWF), Tekla Healthcare Investors (HQH) and General American Investors (GAM).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Nasdaq Biotechnology ETF investors own include NVIDIA (NVDA), Alibaba Group (BABA), Walt Disney (DIS), Netflix (NFLX), Tesla (TSLA), Cisco Systems (CSCO), Paypal (PYPL), Bank of America (BAC), Micron Technology (MU) and Johnson & Johnson (JNJ).

iShares Nasdaq Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."

iShares Nasdaq Biotechnology ETF's stock is owned by a variety of institutional and retail investors. Top institutional investors include CHURCHILL MANAGEMENT Corp (2.24%), PNC Financial Services Group Inc. (0.91%), Envestnet Asset Management Inc. (0.60%), Total Investment Management Inc. (0.42%), First Republic Investment Management Inc. (0.38%) and Raymond James & Associates (0.29%).

IBB stock was sold by a variety of institutional investors in the last quarter, including Estate Counselors LLC, Sawtooth Solutions LLC, AE Wealth Management LLC, Janney Capital Management LLC, Bank of Nova Scotia, Simplex Trading LLC, Quattro Financial Advisors LLC, and Fulton Bank N. A..

IBB stock was acquired by a variety of institutional investors in the last quarter, including CHURCHILL MANAGEMENT Corp, Envestnet Asset Management Inc., Total Investment Management Inc., Advisors Preferred LLC, DAVENPORT & Co LLC, SG Americas Securities LLC, PNC Financial Services Group Inc., and Cambridge Investment Research Advisors Inc..

Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of IBB stock can currently be purchased for approximately $133.81.

iShares Nasdaq Biotechnology ETF has a market capitalization of $9.43 billion.